Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$555,928
-$106,652 QoQ
Shares Held
424,373
+1.2% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 130 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. LCTX ranks #241 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in LCTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $555,928 424,373
2026-03-31 $662,580 419,355
2025-12-31 $330,406 197,849
2025-09-30 $394,504 233,436
2025-06-30 $94,011 103,312
2025-03-31 $72,435 160,973
2024-12-31 $19,056 38,115
2024-09-30 $1,248,901 1,372,422
2024-06-30 $1,360,925 1,360,925
2024-03-31 $1,940,694 1,311,281
2023-12-31 $25,999 23,853
2023-09-30 $7,556 6,404
2023-06-30 $101,815 72,210
2023-03-31 $2,165,668 1,443,779
2022-12-31 $1,203 1,029
2022-09-30 $1,137 1,007
2022-06-30 $17,380 11,000
2022-03-31 $16,940 11,000
2021-12-31 $86,344 35,243
2021-09-30 $29,211 11,592
2021-06-30 $49,671 17,429
2021-03-31 $65,848 28,021
2020-12-31 $22,815 12,964
2020-09-30 $12,185 12,964
2020-06-30 $144,946 166,607
2020-03-31 $13,310 16,039